About MRL Pharma
MRL Pharma is a company based in India. MRL Pharma offers products and services including Tablets and Injections.
- Headquarter India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Social X Instagram
- Legal Name Mrl Pharma Private Limited
- Date of Incorporation 04 Mar, 2020
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹6.58 Cr
FY 2024 · +56% YoY
- Net Profit₹12.9 Lakh
FY 2024 · 2% margin
- EBITDA₹37.2 Lakh
FY 2024 · 6% margin
Associated legal entities of MRL Pharma
MRL Pharma operates through Mrl Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Mrl Pharma Private Limited CIN U51909DL2020PTC362594 | Active | 04 Mar 2020 | New Delhi, Delhi | ₹6.6 Cr | – | 2 | View details |
Products & Services of MRL Pharma
MRL Pharma offers a comprehensive portfolio of products and services, including Tablets and Injections.
Tablets are developed and distributed by MRL Pharma for various health treatments, ensuring they meet safety and effectiveness standards.
Injections are manufactured and supplied by MRL Pharma as part of its range of medications for medical use.
Board of directors of Mrl Pharma Private Limited (MRL Pharma)
Mrl Pharma Private Limited is the primary company behind MRL Pharma. The board of Mrl Pharma Private Limited currently have 2 directors; the longest-serving is Shobhit Tyagi, appointed in 2022. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Shobhit Tyagi DIN 08246603 | Director | 01 Apr 2022 | 4 yrs 6 mo | Mrl Pharma Private Limited |
| Ahsan Ahmad DIN 07474095 | Director | 01 Apr 2022 | 4 yrs 6 mo | Mrl Pharma Private Limited |
Financials of MRL Pharma
Figures of Mrl Pharma Private Limited, the primary company behind MRL Pharma, for FY 2024. Revenue was ₹6.58 Cr (+56% year on year). Net profit was ₹12.9 Lakh (2% margin). EBITDA was ₹37.2 Lakh (6% margin). Revenue has grown at a compounded annual rate of +109% over three years.
- ₹6.58 CrRevenue · FY 2024 · +56% YoY
- ₹12.9 LakhNet profit · 2% margin
- ₹37.2 LakhEBITDA · 6% margin
- ₹1 LakhPaid-up capital
- +109%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Mrl Pharma Private Limited are on its company page.
Detailed financial statements for MRL Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to MRL Pharma
10 companies that operate in the same segment as MRL Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about MRL Pharma
MRL Pharma is headquartered in India.
The primary company behind MRL Pharma, Mrl Pharma Private Limited, reported revenue of ₹6.58 Cr for FY 2024, up 56% year on year.
At MRL Pharma, efforts are dedicated to enhancing the quality of life through innovative healthcare solutions. High-quality medications and products are developed and delivered by the company, with a focus on maintaining rigorous standards in research, development, manufacturing, and quality control to ensure safety and reliability. Commitment to employee growth and sustainable practices is emphasized, while serving industries like human pharmaceuticals and medical devices across India. Products are tailored to meet community needs, driven by a patient-centered approach that prioritizes well-being and social responsibility.
MRL Pharma offers Tablets and Injections.
MRL Pharma operates through Mrl Pharma Private Limited.
The legal entities of MRL Pharma currently have 2 directors, including Shobhit Tyagi, Ahsan Ahmad.